
|Articles|March 1, 2012
Introduction to Panel Discussion Topic
Moderator, Dr. Chernew, begins this discussion by asking the panelists what a PCMH actually is and when they were developed. Dr. Ginsburg touches upon the structural aspects of the PCMH and how physicians are paid through this model.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
60% of US Women Face Barriers to Postpartum, Mental Health Care
4
Counseling Vitiligo Patients on Time to Repigmentation
5
